BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21424059)

  • 21. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y; Goldberg ID; Shi YE
    Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):659-66. PubMed ID: 11212843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
    Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
    Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
    Brabletz T; Jung A; Dag S; Reu S; Kirchner T
    Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TIMPs tango with MMPs and more in the central nervous system.
    Crocker SJ; Pagenstecher A; Campbell IL
    J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
    Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
    Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
    Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
    J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
    O-Charoenrat P; Rhys-Evans PH; Eccles SA
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
    Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
    Jeffery N; McLean MH; El-Omar EM; Murray GI
    Histopathology; 2009 Jun; 54(7):820-8. PubMed ID: 19635101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide.
    Zhang X; Wang HM; Lin HY; Liu GY; Li QL; Zhu C
    Placenta; 2004 Apr; 25(4):243-52. PubMed ID: 15028415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
    Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
    Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
    Roca F; Mauro LV; Morandi A; Bonadeo F; Vaccaro C; Quintana GO; Specterman S; de Kier Joffé EB; Pallotta MG; Puricelli LI; Lastiri J
    J Surg Oncol; 2006 Feb; 93(2):151-60. PubMed ID: 16425303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
    Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
    Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
    Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2015 Jul; 47(1):370-6. PubMed ID: 25997494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
    Ogasawara S; Yano H; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Kojiro M
    Oncol Rep; 2005 Jun; 13(6):1043-8. PubMed ID: 15870919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.